Imaging: Clinical Trials

3 trials of Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Active not recruiting 1

Follow Imaging: new trials by email Literature Review of Imaging trials Research Report on Imaging

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Biopsy Procedure, Biospecimen Collection, Carboplatin - Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma
Phase 3Active not recruitingNRG Oncology4502019-09-202026-03-24
Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Vitamin D, Placebo, Imaging - Multiple Sclerosis
Phase 3CompletedCentre Hospitalier Universitaire de Nīmes3162013-07-162024-01-12
Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases
imaging - Brain Metastases, Growing Lesions After Radiosurgical Treatment
Phase 3CompletedAssistance Publique - Hôpitaux de Paris902010-06-012016-04-11

Conditions studied

Brain Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Immune System Diseases (1)  ·  Multiple Sclerosis (1)  ·  Ovarian Neoplasms (1)  ·  Recurrence (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  NRG Oncology (1)

Countries

France (2)  ·  Canada (1)  ·  Ireland (1)  ·  Martinique (1)  ·  Peru (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Amanda N Fader (1)  ·  Eric Thouvennot, MD, PhD (1)  ·  Eric Thouvenot, MD, PhD (1)

Results publications

PMID 40058134, PMID 40063041

NIH funding

2009 (1), U10CA180868 (1)